Can we avoid dose escalation for intermediate-risk prostate cancer in the setting of short-course neoadjuvant androgen deprivation?

Παρόμοια τεκμήρια

• Can we avoid high levels of dose escalation for high-risk prostate cancer in the setting of androgen deprivation?
  ανά: Shakespeare, Thomas P, κ.ά.
  Έκδοση: (2016)
• Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancer
  ανά: Wilcox, Shea W, κ.ά.
  Έκδοση: (2014)
• Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial
  ανά: Parker, Chris C, κ.ά.
  Έκδοση: (2024)
• External Beam Radiation Therapy or Brachytherapy With or Without Short Course Neoadjuvant Androgen Deprivation Therapy: Results of a Multi-Center, Prospective Study of Quality of Life
  ανά: Gay, Hiram Alberto, κ.ά.
  Έκδοση: (2017)
• The role of androgen deprivation therapy on biochemical failure and distant metastasis in intermediate-risk prostate cancer: effects of radiation dose escalation
  ανά: Ludwig, Michelle S, κ.ά.
  Έκδοση: (2015)